Vivimed Labs Limited has issued a notice regarding a scheduled meeting of its Board of Directors. The meeting is set to be held on Friday, July 17, 2026, at the company's location in Hyderabad.
The primary agenda for this board meeting includes considering and approving the Audited Financial Results for both standalone and consolidated operations. These results cover the quarter and financial year ending March 31, 2026.
The notice indicates that the board may also address "any other items" beyond the financial results, though these are not specified in the disclosure.
This communication is made pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements), 2015, indicating compliance with regulatory disclosure requirements for listed companies.
The notice was signed by Yugandhar Kopparthi, Company Secretary, on behalf of Vivimed Labs Limited.
Financial Impact
Financial impact not quantified in the disclosure. The meeting is scheduled to review and approve already completed financial results for the specified periods.